FORUS licenses BESREMi for Polycythemia Vera treatment in Canada from PharmaEssentia.
Read more
Exactech's Truliant 3D Tibial Implant receives FDA clearance for Knee Replacement Surgery.
Read more
Biomodal's 6-base genome data enhances early detection of Colorectal Cancer, presented at ASHG 2024.
Read more
Aileron and Advancium partner to evaluate ALRN-6924 for Retinoblastoma treatment.
Read more
Eisai completes FDA submission for LEQEMBI subcutaneous dosing for early Alzheimer's Disease under Fast Track status.
Read more
GlycoMimetics to merge with Crescent Biopharma, focusing on oncology therapeutics for solid tumors.
Read more
Bionano Genomics announces $3 million direct offering under Nasdaq rules for genome analysis solutions.
Read more
1upHealth appoints Andrew Boyd as CEO to drive growth and interoperability in healthcare data management.
Read more
Diadem's p53-specific antibody shows promise for early Alzheimer's Disease detection at CTAD 2024.
Read more
AbbVie partners with EvolveImmune to develop next-gen biotherapeutics for solid and hematologic malignancies.
Read more
Abionic's CAPSULE PSP gains FDA approval for early Sepsis detection; Fapon to introduce PSP solution in China.
Read more
Novartis reports 10% sales growth in Q3, raises 2024 guidance, and achieves key FDA approvals for Kisqali and Fabhalta.
Read more
Tizona expands Phase 1b trial of TTX-080 with cetuximab for metastatic Colorectal Neoplasms.
Read more
Acumen's pTau217 assay improves participant screening in Phase 2 Alzheimer's Disease trial, reducing unnecessary procedures.
Read more
Hope Biosciences' stem cell therapy shows significant efficacy in Phase II trial for Multiple Sclerosis.
Read more
Biofrontera's Ameluz®-PDT shows significant efficacy in Phase 3 trial for Superficial Basal Cell Carcinoma.
Read more
Sutro Biopharma initiates trial for Luvelta in pediatric patients with CBF/GLIS Acute Myeloid Leukemia.
Read more
Teva's TEV-'749 shows improved social functioning in schizophrenia patients in Phase 3 SOLARIS trial.
Read more
Elektrofi secures $112.25M to expand GMP manufacturing and accelerate clinical development of biologic therapies.
Read more
Ataraxis AI launches AI-native diagnostic test for Breast Neoplasms, enhancing precision medicine with 30% higher accuracy than current standards.
Read more
Evogene partners with Google Cloud to enhance small molecule design using AI for drug development and agriculture.
Read more
Sagimet Biosciences to start Phase 3 trials for Denifanstat in Metabolic Dysfunction-Associated Steatohepatitis by end of 2024.
Read more
Inocras launches MRDVision, a WGS-based MRD detection tool with one-in-a-million sensitivity, leveraging Ultima's ppmSeq technology.
Read more
Roche's Itovebi doubles progression-free survival in HR-positive advanced breast cancer, FDA-approved for PIK3CA mutation.
Read more
Evommune secures $115M to advance treatments for Chronic Urticaria and Atopic Dermatitis.
Read more
